John Libbey Eurotext

European Journal of Dermatology

Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study Article à paraître

Tableaux

Auteurs
1 Dermatology Unit,
“Cristo Re” General Hospital,
Rome, Italy
2 1st Dermatological Clinic,
IDI-IRCCS - FLMM,
Rome, Italy
3 Clinical Epidemiology Unit,
IDI-IRCCS, FLMM,
Rome, Italy
4 Hospital Information System,
IDI-IRCCS, FLMM,
Rome, Italy
5 Medical Direction of the IDI-IRCCS, FLMM,
Rome, Italy
* Reprints

Psoriasis is a chronic inflammatory disease of the skin and joints that affects 2-3% of the population worldwide [1]. It has been suggested that patients with chronic inflammatory conditions, such as rheumatoid arthritis [2], Crohn's disease [3], and psoriasis [4], may be at increased risk of cancer due to impaired immunosurveillance resulting from the effect of chronic inflammation [5-7] and immunosuppressive agents. Previous exposure to systemic treatment, including immunosuppressive drugs, methotrexate, [...]